BidPal® Resources Position Nonprofits for Successful Year-End Fundraising Season
Nov 09, 2017 11:00 am UTC| Business
INDIANAPOLIS, Nov. 09, 2017 -- BidPal®, the leading mobile fundraising platform helping nonprofits raise more money and connect with more donors, has rolled out a number of resources designed to help nonprofits benefit...
response:now Launches in US to Deliver AI powered Market Research
Nov 09, 2017 11:00 am UTC| Business
PRAGUE, Czech Republic, Nov. 09, 2017 -- response:now, which provides AI-powered market research, today announced its launch in the United States. Successfully operating in the European market since earlier this year,...
Mesoblast Presents Corporate Update at 26TH Annual Credit Suisse Healthcare Conference
Nov 09, 2017 11:00 am UTC| Business
NEW YORK and MELBOURNE, Australia, Nov. 09, 2017 -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today presented a corporate update at the 26th Annual Credit Suisse Healthcare Conference held in Scottsdale, Arizona. ...
GDS Reports Third Quarter 2017 Results
Nov 09, 2017 11:00 am UTC| Business
SHANGHAI, China, Nov. 09, 2017 -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ:GDS), a leading developer and operator of high-performance data centers in China, today announced its unaudited...
Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference
Nov 09, 2017 11:00 am UTC| Business
JERSEY, Channel Islands, Nov. 09, 2017 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the...
Nov 09, 2017 11:00 am UTC| Business
Total Net Revenue (“Revenue”) increased 1.3% to $227.6 million in the third quarter of 2017 from $224.6 million in the third quarter of 2016: Adjusting for the sale of the Rhode Island facilities, Revenue increased 1.9% as...
Nov 09, 2017 11:00 am UTC| Business
45 Abstracts Demonstrate the Value of the nCounter Platform for Immuno-Oncology Research Studies Indicate the Clinical Relevance of the Tumor Inflammation Signature for Multiple Immunotherapies SEATTLE, Nov. 09, 2017 ...